Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:33 AM ET 8-K
Financial Results Citizens Community Bancorp Inc. CZWI

Citizens Community Bancorp Financial Results

Citizens Community Bancorp reported Q3 2026 net income of $5.4 million, or $0.56 per diluted share, driven by a higher net interest margin and lower provision for credit losses. The company also announced a 14% increase in its quarterly dividend to $0.12 per share and repurchased 70,000 shares during the quarter.

“The strong quarter reflected continued execution of our strategic plan with lower provision expense and the net interest margin and margin dollar increase being the highlight. We also saw loan originations outpace a modest pickup in loan payoffs, ten percent higher non-interest income from the linked quarter and non-interest expenses were controlled other than higher variable performance-based compensation expense which accounted for the uptick from last quarter.”

Stephen Bianchi, Chairman, President & CEO
8:32 AM ET 8-K
Leadership Change Herc Holdings Inc HRI

Herc Holdings Leadership Change

Herc Holdings announced a planned leadership succession where Aaron Birnbaum, current President, will succeed Lawrence H. Silber as CEO effective January 1, 2027. Silber, who has led the company since 2015, will transition to the role of Executive Chairman, while Michael A. Kelly will become Lead Director.

8:31 AM ET 10-Q
Financial Results Seebeks Corp.

Seebeks Q1 2026 Results: Net Loss of $11.9K, Loss Narrows

Seebeks Corp. reported its first revenues of $10,100 for the quarter ended September 30, 2026, compared to zero in the prior year, while narrowing its net loss to $11,916. Despite the revenue growth, the company maintains an accumulated deficit of $65,073 and expressed substantial doubt regarding its ability to continue as a going concern without additional capital.

Key figure
Net loss $11.9K
8:31 AM ET 8-K
Leadership Change Agassi Sports Entertainment Corp. AASP

Agassi Sports Entertainment Leadership Change

Agassi Sports Entertainment Corp. expanded its Board of Directors to three members and appointed Clive G. Brookes as an independent director. Mr. Brookes will also serve as Chairman of the newly formed Audit, Nominating and Corporate Governance, and Compensation Committees.

8:31 AM ET 8-K
Financial Results Business First Bancshares, Inc. BFST

Business First Bancshares Financial Results

Business First Bancshares reported Q3 2026 net income available to common shareholders of $23.2 million, or $0.71 per diluted share, driven by a 13 basis point expansion in net interest margin to 3.86%. The company also declared a quarterly common dividend of $0.15 per share and repurchased $6.3 million of its own stock during the quarter.

Term
Q3 2026

“Our third quarter showed what disciplined execution can deliver. We completed the conversion of Progressive Bank, and I’m grateful to our North Louisiana teammates and clients for helping make it a seamless transition. We grew loans and deposits at a balanced pace appropriate to our level of capital strength, and we did so while expanding our net interest margin by 12 basis points and keeping non-interest expenses in check.”

Jude Melville, chairman, president, and CEO of Business First
8:30 AM ET 8-K
Business Update SS Innovations International, Inc. SSII

SS Innovations International Business Update

SS Innovations International showcased its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console during successful long-distance telesurgeries at major medical conferences in Barcelona and New Delhi. The demonstrations included a cardiac procedure performed remotely from 7,500 miles away, highlighting the system's ultra-low latency and remote surgical capabilities.

8:30 AM ET 8-K
Stock Buyback Empery Digital Inc. EMPD

Empery Digital Stock Buyback Update

Empery Digital Inc. announced the resumption of its $200 million stock repurchase program, repurchasing 122,955 shares during the week ending October 23, 2026. Approximately $50 million remains available under the current authorization. The company also provided updates on its balance sheet, including holdings of 1,018 bitcoin and a pending $65 million investment in a Midwest AI data center.

8:25 AM ET 8-K
M&A Deal SHF Holdings, Inc. SHFS

SHF Holdings M&A Deal with Opifex Media Inc.

SHF Holdings (Safe Harbor) signed a non-binding term sheet to combine with Opifex Media, a Beverly Hills-based media holding company focused on the creator economy. The transaction is designed to create a Nasdaq-listed holding company with two distinct businesses and support Safe Harbor's plan to maintain its Nasdaq listing. Following the closing, Opifex would become a wholly owned subsidiary of Safe Harbor and the combined company would operate under a new name.

Counterparty
Opifex Media Inc.
8:16 AM ET 8-K
Other 8-K Filing K&F Growth Acquisition Corp. II KFII

K&F Growth Acquisition Corp. II Other 8-K Filing

K&F Growth Acquisition Corp. II issued 9,583,332 Class A ordinary shares to its sponsor upon the conversion of an equal number of Class B ordinary shares. The conversion was conducted on a 1-for-1 basis under the Section 3(a)(9) registration exemption and did not involve a new capital raise. Following the transaction, only one Class B ordinary share remains outstanding.

Counterparty
K&F Growth Acquisition LLC II
8:15 AM ET 8-K
Business Update ASP Isotopes Inc. ASPI

ASP Isotopes Business Update

ASP Isotopes announced that its subsidiary Renergen Limited has achieved stable liquid helium production at the Virginia Gas Project in South Africa. The facility is now accumulating liquid helium in cryogenic storage ahead of initial deliveries to contracted offtakers, with a ramp-up to nameplate capacity expected during Q4 2026.

Counterparty
Renergen Limited
8:13 AM ET 8-K
Clinical Trial Data Aptevo Therapeutics Inc. APVO

Aptevo Therapeutics Clinical Trial Data

Aptevo Therapeutics reported clinical data from its Phase 1b RAINIER trial showing that 21% of frontline AML patients treated with mipletamig combination therapy advanced to potentially curative stem cell transplants. This transplant rate compares favorably to historical standard-of-care results (0.7% in the VIALE-A trial) for patients initially deemed unfit for intensive chemotherapy. The company expects to conclude dose optimization by year-end and initiate a Phase 2 trial in the first half of 2027.

8:12 AM ET Form 4
Insider Selling Maplebear Inc. CART

Maplebear CFO Emily Reuter Sells $2.75M of Stock

Emily Reuter, CFO, sold 50,000 shares of Maplebear Inc. at $55.00 a share, worth $2.75M in total on Oct 23, 2026. Shares held after the trade: 599,337 (-7.7%).

Value
$2.75M
Shares
50,000
Price
$55.00
Role
CFO
Holding change
-7.7%
Trade date
Oct 23, 2026
8:12 AM ET 8-K
Financial Results Medifast Inc MED

Medifast Financial Results

Medifast reported Q3 2026 revenue of $72.0 million, a 19.4% decrease year-over-year, primarily due to a 47.7% decline in active earning coaches. The company posted a net loss of $17.5 million as it continues to execute its '3.0 strategy' focused on metabolic health and GLP-1 medication support. Management highlighted improved coach productivity and expects to return to profitability in the fourth quarter.

Term
Q3 2026

“The third quarter was about execution. With Trilivy now live, Reset Fuelings in our coaches’ hands, and our new compensation plan and Coach Hub launched, the major pieces of our 3.0 strategy are now in market. Revenue came in line with our guidance, and coach productivity improved year-over-year for the fourth consecutive quarter. Those are the kinds of indicators that have historically come before coach growth and revenue growth.”

Nick Johnson, Medifast's Chief Executive Officer

“The world is facing an unprecedented metabolic health crisis, and medication alone will not solve it. Lasting health requires lasting habits, and that is exactly what we were built to deliver. With nutritionally optimized products continually enhanced by research-backed ingredients that target metabolic health, and the proven power of coaching and our community, no one is better positioned to lead the way.”

Dr. Wayne Scott Andersen, Founder of the Mission, Independent Trilivy Coach
8:09 AM ET 8-K
Business Update DeFi Development Corp. DFDV

DeFi Development Business Update

DeFi Development Corp. reported that its SOL treasury holdings increased by 5,346 to a total of 2,595,612 SOL as of October 23, 2026. The company also announced that the annual dividend rate for its Series C Perpetual Preferred Stock (CHAD) will increase from 13% to 14% effective November 2, 2026.

8:09 AM ET Form 4
Insider Selling Maplebear Inc. CART

Maplebear President and CEO Chris Rogers Sells $1.32M of Stock

Chris Rogers, President and CEO, sold 24,060 shares of Maplebear Inc. at $55.04 a share, worth $1.32M in total on Oct 23, 2026. Shares held after the trade: 892,576 (-2.6%).

Value
$1.32M
Shares
24,060
Price
$55.04
Role
President and CEO
Holding change
-2.6%
Trade date
Oct 23, 2026
8:05 AM ET Form 4
Insider Selling Maplebear Inc. CART

Maplebear CLO Morgan Fong Sells $938K of Stock

Morgan Fong, CLO, sold 18,390 shares of Maplebear Inc. at $50.93 to $51.39 a share (average $51.00) in 2 transactions, worth $938K in total on Oct 22, 2026. Shares held after the trade: 529,911 (-0.6%).

Value
$938K
Shares
18,390
Average price
$51.00
Role
CLO
Holding change
-0.6%
Trade date
Oct 22, 2026
8:01 AM ET 8-K
Clinical Trial Data Oruka Therapeutics, Inc. ORKA

Oruka Therapeutics Clinical Trial Data

Oruka Therapeutics announced positive Week 16 results from its Phase 2b EVERLAST-B clinical trial of ORKA-001 in patients with moderate-to-severe plaque psoriasis. The trial met its primary endpoint with 61% of patients in the high-dose (600 mg) group achieving complete skin clearance (PASI 100) compared to 0% for placebo, supporting the planned initiation of Phase 3 trials in the first half of 2027.

8:01 AM ET 8-K
Business Update Super League Enterprise, Inc. SLE

Super League Enterprise Business Update

Super League Enterprise, Inc. announced that it purchased four Bitcoin at an average price of approximately $80,581.26 per coin between October 22 and October 25, 2026. This acquisition is part of the company's strategy to explore Bitcoin as a treasury reserve asset alongside its existing cash and cash equivalents.

8:01 AM ET 8-K
Financial Results MainStreet Bancshares, Inc. MNSB

MainStreet Bancshares Financial Results

MainStreet Bancshares reported Q3 2026 net income of $3.6 million and earnings per share of $0.43. Net interest income rose to $18.8 million, marking the fourth consecutive quarterly increase, though results were impacted by a $1.9 million provision for credit losses related to commercial real estate adjustments.

Term
Q3 2026

“No sector is entirely immune to broader economic realignments, and we are managing through commercial real estate adjustments with eyes wide open.”

Jeff W. Dick, Chairman and CEO

“Resolving credit challenges in a transitioning commercial real estate environment requires active engagement and patience. We are methodically working through nonperforming assets and prioritizing long-term portfolio quality over short-term expediency.”

Chris Johnston, Chief Credit Officer
8:00 AM ET 8-K
Reverse Stock Split Adagio Medical Holdings, Inc. ADGM

Adagio Medical Holdings Reverse Stock Split

Adagio Medical Holdings stockholders approved a proposal for a reverse stock split of the company's common stock at a ratio between 1-for-10 and 1-for-500. The final ratio will be determined by the Board of Directors at its discretion to consolidate outstanding shares.

8:00 AM ET 8-K
Financial Results Alliance Resource Partners LP ARLP

Alliance Resource Partners Financial Results

Alliance Resource Partners reported Q3 2026 total revenues of $603.0 million and net income of $139.6 million, representing a 46.8% year-over-year increase in net income. The results were driven by record oil & gas royalty revenues following $223.5 million in acquisitions and improved coal operations expense management.

Term
Q3 2026
8:00 AM ET 8-K
M&A Deal GameSquare Holdings, Inc. GAME

GameSquare Holdings M&A Deal with FanEngine Holdings Ltd.

GameSquare Holdings completed the acquisition of sports, music, and entertainment IP assets from FanEngine Holdings Ltd. in exchange for 5,439,416 shares of common stock. The deal includes rights to franchises like Peaky Blinders and Simon’s Cat, with sellers eligible for up to $50 million in contingent cash earnouts and additional shares based on future revenue milestones.

Counterparty
FanEngine Holdings Ltd.

“Closing this transaction marks the start of a new chapter in GameSquare’s evolution. We have built best-in-class capabilities to measure, reach and engage audiences at scale. With the ability to own the fan relationship and earn from it repeatedly, FanEngine adds an important piece to our ecosystem. We expect that to show up in our results quickly, with FanEngine contributing to our 2026 proforma outlook and supporting 2027 guidance of more than $150 million in revenue and more than $30 million in adjusted EBITDA. Our focus now is integrating the acquisition and executing new commercial opportunities for our owned IP assets.”

Justin Kenna, Chief Executive Officer of GameSquare
8:00 AM ET 8-K
Loan & Debt Space Exploration Technologies Corp SPCX

Space Exploration Technologies $40B Debt Financing with Apollo Global Management, Inc.

Space Exploration Technologies Corp. entered into a binding commitment letter for a $40 billion master finance lease with an entity managed by Apollo Global Management. The financing will fund the acquisition of graphics processing unit (GPU) pods and related equipment for use at the company's data centers, with lease schedules expected to commence in the first half of 2027.

Value
$40B
Counterparty
Apollo Global Management, Inc.
Term
5 years
8:00 AM ET 8-K
M&A Deal Valion Bio, Inc. VBIO

Valion Bio M&A Deal Update

Valion Bio has received unsolicited acquisition inquiries from third parties regarding its wholly owned CDMO subsidiary, Velocity Bioworks. The company has retained an investment bank to evaluate strategic options, including a potential sale, while prioritizing the retention of manufacturing rights for its lead drug candidate, Entolimod.

8:00 AM ET 8-K
Business Update Strive, Inc. ASST

Strive Business Update

Strive, Inc. announced it purchased 6,182 bitcoin between October 17 and October 23, 2026, at an average price of $82,732 per bitcoin. The company also provided a weekly update on its treasury holdings, reporting a total of 43,000 bitcoin held and a cash balance of $504.4 million as of October 23, 2026.

7:51 AM ET 8-K
Clinical Trial Data Xencor Inc XNCR

Xencor Clinical Trial Data

Xencor announced updated Phase 1 clinical trial results for XmAb819, an ENPP3 x CD3 bispecific T-cell engager, in patients with advanced clear cell renal cell carcinoma (ccRCC). The company also provided a cash runway update, expecting current resources to fund operations into 2029, and plans to start a potential registration-enabling study for XmAb819 in 2027.

7:51 AM ET 8-K
Capital Raise Strive, Inc. ASST

Strive Capital Raise

Strive, Inc. entered into a sales agreement to establish an at-the-market (ATM) offering program for up to $1.0 billion of its 15.00% Series A Perpetual SATS Preferred Stock. The company intends to use the proceeds for general corporate purposes, including the acquisition of bitcoin and bitcoin-related products, working capital, and potential share repurchases.

Counterparty
Cantor Fitzgerald & Co.
7:31 AM ET 8-K
Loan & Debt Soluna Holdings, Inc SLNH

Soluna Holdings $28.7M Debt Financing with Generate Capital, PBC

Soluna Holdings has fully repaid and terminated its $28.7 million credit facility with Generate Capital, PBC. The repayment releases liens on project assets, facilitating the transition of power to the Dorothy 3 AI campus and reducing the company's total debt principal by 76% from June 30, 2026 levels.

Value
$28.7M
Counterparty
Generate Capital, PBC
7:26 AM ET Form 4
Insider Selling Mercury Systems Inc MRCY

Mercury Systems EVP, CLO & Corp Sec Stuart Kupinsky Sells $76K of Stock

Stuart Kupinsky, EVP, CLO & Corp Sec, sold 1,000 shares of Mercury Systems Inc at $76.00 a share, worth $76K in total on Oct 21, 2026. Shares held after the trade: 59,971 (-1.6%).

Value
$76K
Shares
1,000
Price
$76.00
Role
EVP, CLO & Corp Sec
Holding change
-1.6%
Trade date
Oct 21, 2026
7:15 AM ET 8-K
Executive Compensation Fedex Corp FDX

Fedex Executive Compensation

FedEx Corporation has appointed Jamere Jackson as Executive Vice President and Chief Financial Officer, effective November 30, 2026. Mr. Jackson, who joins from AutoZone, will receive an annual base salary of $1,000,000 and a $2,000,000 signing bonus payable in two installments.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.